Kairos Pharma, LTD.

Ownership Transactions Reported by 8 Insiders

Symbol
KAPA on NYSE
Location
2355 Westwood Blvd. #139, Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 12/6/2024

Kairos Pharma, LTD. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John S. Yu CEO and Chairman, Director, 10%+ Owner $6.1M Oct 8, 2025
Neil Bhowmick Chief Scientific Officer $1.81M Jan 1, 2025
Ramachandran Murali VP of Research and Development $329K Oct 8, 2025
Doug Samuelson Chief Financial Officer $322K Oct 8, 2025
Hyun W. Bae Director $63.8K Sep 16, 2024
Rahul Singhvi Director $54.1K Oct 8, 2025
Hansoo Michael Keyoung Director $32K Sep 16, 2025
Rosemary Mazanet Director Sep 16, 2024

Recent Insider Transactions by Companies or Individuals for Kairos Pharma, LTD.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.